Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

AVAN

Avant Immunotherapeutics (MM) (AVAN)

Avant Immunotherapeutics (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AVAN
DateTimeSourceHeadlineSymbolCompany
09/29/20084:02PMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
09/29/200810:43AMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
09/29/200810:42AMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
09/29/200810:42AMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
09/29/200810:42AMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
09/29/200810:41AMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
09/29/200810:41AMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
09/29/20087:00AMBusiness WireAVANT Immunotherapeutics Announces Name Change to Celldex TherapeuticsNASDAQ:AVANAvant Immunotherapeutics (MM)
09/23/20085:14PMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
09/19/20089:28AMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:AVANAvant Immunotherapeutics (MM)
09/18/20083:00PMBusiness WireAVANT CEO To Present at the UBS 2008 Global Life Sciences Conference September 23NASDAQ:AVANAvant Immunotherapeutics (MM)
08/13/20083:53PMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:AVANAvant Immunotherapeutics (MM)
08/08/20083:16PMBusiness WireAVANT CEO to Present at the 28th Annual Canaccord Adams Global Growth ConferenceNASDAQ:AVANAvant Immunotherapeutics (MM)
08/06/20089:52AMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
08/06/20087:46AMBusiness WireCORRECTING and REPLACING AVANT Reports Second Quarter and Six Month Financial ResultsNASDAQ:AVANAvant Immunotherapeutics (MM)
08/06/20087:00AMBusiness WireAVANT Reports Second Quarter and Six Month Financial ResultsNASDAQ:AVANAvant Immunotherapeutics (MM)
08/04/200812:56PMBusiness WireAVANT to Report Second Quarter 2008 Financial Results on August 6, 2008NASDAQ:AVANAvant Immunotherapeutics (MM)
07/28/20084:25PMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
07/18/20083:59PMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
07/18/20081:05PMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:AVANAvant Immunotherapeutics (MM)
06/26/20083:47PMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:AVANAvant Immunotherapeutics (MM)
06/18/200810:13AMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Securities Registration: Employee Benefit Plan (S-8)NASDAQ:AVANAvant Immunotherapeutics (MM)
06/11/20087:00AMBusiness WireAVANT Announces Vaccine Adjuvant Licenses with 3MNASDAQ:AVANAvant Immunotherapeutics (MM)
06/09/20083:29PMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
06/04/20089:00AMBusiness WireAVANT CEO to Present at the Needham & Company Biotechnology & Medical Technology ConferenceNASDAQ:AVANAvant Immunotherapeutics (MM)
06/04/20086:00AMBusiness WireNIH Initiates Phase 1 Safety Study of AVANT's Oral Combined Enterotoxigenic E. coli-Cholera VaccineNASDAQ:AVANAvant Immunotherapeutics (MM)
06/03/20087:30AMMarketwiredMarket Pulse Breaking News Alert for Tuesday, June 3, 2008: NCEN – NACEL Energy Achieves Objectives With 640 MW Wind Power in DeNASDAQ:AVANAvant Immunotherapeutics (MM)
06/02/20083:56PMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
06/02/20081:32PMMarketwiredNew Analyst Reports for AVANT IMMUNOTHERAPEUTICS, CANADIAN SOLAR INC, LIBERTY MEDIA HOLDING CORPORATION, and BED BATH AND BEYONDNASDAQ:AVANAvant Immunotherapeutics (MM)
05/30/200812:54PMEdgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
 Showing the most relevant articles for your search:NASDAQ:AVAN